Adherence and patients’ experiences with capecitabine.
Completed
- Conditions
- Colorectal cancer, gastric cancer and breast cancer.
- Registration Number
- NL-OMON21382
- Lead Sponsor
- VU University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 66
Inclusion Criteria
Cancer patients starting with capecitabine.
Exclusion Criteria
Younger than 18 years of age or insufficient knowledge of the Dutch language.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence rate: A patient is adherent with the intake of 85% or more of the prescribed medication.
- Secondary Outcome Measures
Name Time Method 1. Number and grade of side-effects;<br /><br>2. Attitude towards disease;<br /><br>3. Beliefs and attitude towards medicines.